Daniel L Kisner - Net Worth and Insider Trading

Daniel L Kisner Net Worth

The estimated net worth of Daniel L Kisner is at least $123,758 dollars as of 2024-04-25. Daniel L Kisner is the Director of Zynerba Pharmaceuticals Inc and owns about 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $98,511. Daniel L Kisner is the Director of Dynavax Technologies Corp and owns about 1,500 shares of Dynavax Technologies Corp (DVAX) stock worth over $16,830. Daniel L Kisner is also the Director of Oncternal Therapeutics Inc and owns about 500 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $4,415. Besides these, Daniel L Kisner also holds Conatus Pharmaceuticals Inc (CNAT) . Details can be seen in Daniel L Kisner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel L Kisner has not made any transactions after 2023-06-14 and currently still holds the listed stock(s).

Transaction Summary of Daniel L Kisner

To

Daniel L Kisner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel L Kisner owns 7 companies in total, including Histogen Inc (HSTO) , Oncternal Therapeutics Inc (ONCT) , and Zynerba Pharmaceuticals Inc (ZYNE) among others .

Click here to see the complete history of Daniel L Kisner’s form 4 insider trades.

Insider Ownership Summary of Daniel L Kisner

Ticker Comapny Transaction Date Type of Owner
HSTO Histogen Inc 2014-02-07 director
ONCT Oncternal Therapeutics Inc 2020-07-21 director
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 director
DVAX Dynavax Technologies Corp 2013-10-30 director
APEN Apollo Endosurgery Inc 2012-07-30 director
ABUS Arbutus Biopharma Corp 2015-01-01 director
SQNM Sequenom Inc 2004-05-14 director

Daniel L Kisner Latest Holdings Summary

Daniel L Kisner currently owns a total of 4 stocks. Among these stocks, Daniel L Kisner owns 75,778 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of June 14, 2023, with a value of $98,511 and a weighting of 79.6%. Daniel L Kisner owns 1,500 shares of Dynavax Technologies Corp (DVAX) as of October 30, 2013, with a value of $16,830 and a weighting of 13.6%. Daniel L Kisner also owns 500 shares of Oncternal Therapeutics Inc (ONCT) as of July 21, 2020, with a value of $4,415 and a weighting of 3.57%. The other 1 stocks Conatus Pharmaceuticals Inc (CNAT) have a combined weighting of 3.23% among all his current holdings.

Latest Holdings of Daniel L Kisner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYNE Zynerba Pharmaceuticals Inc 2023-06-14 75,778 1.30 98,511
DVAX Dynavax Technologies Corp 2013-10-30 1,500 11.22 16,830
ONCT Oncternal Therapeutics Inc 2020-07-21 500 8.83 4,415
CNAT Conatus Pharmaceuticals Inc 2015-04-08 7,145 0.56 4,001

Holding Weightings of Daniel L Kisner


Daniel L Kisner Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel L Kisner has made a total of 2 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 115 shares on June 14, 2023, which brought Daniel L Kisner around $40.

According to the SEC Form 4 filings, Daniel L Kisner has made a total of 0 transactions in Dynavax Technologies Corp (DVAX) over the past 5 years. The most-recent trade in Dynavax Technologies Corp is the acquisition of 1,000 shares on October 30, 2013, which cost Daniel L Kisner around $10,800.

According to the SEC Form 4 filings, Daniel L Kisner has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 500 shares on July 21, 2020, which cost Daniel L Kisner around $23,800.

More details on Daniel L Kisner's insider transactions can be found in the Insider Trading History of Daniel L Kisner table.

Insider Trading History of Daniel L Kisner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel L Kisner Trading Performance

GuruFocus tracks the stock performance after each of Daniel L Kisner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel L Kisner is -5.98%. GuruFocus also compares Daniel L Kisner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel L Kisner within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel L Kisner's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel L Kisner

Average Return

20.88%

Average return per transaction

Outperforming Transactions

67%

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.35 -5.98 38.85 20.88 1 -21.82
Relative Return to S&P 500(%) 10.57 -7.82 31.57 5.78 -7.58 -30.45

Daniel L Kisner Ownership Network

Ownership Network List of Daniel L Kisner

No Data

Ownership Network Relation of Daniel L Kisner


Daniel L Kisner Owned Company Details

What does Histogen Inc do?

Who are the key executives at Histogen Inc?

Daniel L Kisner is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .

Histogen Inc (HSTO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Histogen Inc Insider Transactions

No Available Data

Daniel L Kisner Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel L Kisner. You might contact Daniel L Kisner via mailing address: 2292 Faraday Avenue, Carlsbad Ca 92008.

Discussions on Daniel L Kisner

No discussions yet.